Status:
WITHDRAWN
Evaluation of COVID-19 IgG Antibodies in Maternal and Cord Blood Samples
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Covid19
Pregnancy Related
Eligibility:
FEMALE
18+ years
Brief Summary
Protocol Summary Study design: Prospective cohort study of pregnant COVID-19 positive patients at delivery. Study Objective: To collect umbilical cord blood and placenta samples at the time of deliv...
Detailed Description
Background The clinical syndrome of coronavirus 2019 (COVID-19), caused by the severe acute respiratory 2 virus (SARS-CoV-2) first began in Wuhan China in December 2019 and subsequently spread global...
Eligibility Criteria
Inclusion
- \- Women admitted for delivery who are known or suspected COVID-19 positive and women were positive at any time during pregnancy who have had standard nasal swab PCR testing for COVID-19.
Exclusion
- \- Patients less than 18 years of age. Patients unable to give consent. Patients who are immunocompromised.
Key Trial Info
Start Date :
January 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04732767
Start Date
January 20 2021
End Date
June 30 2021
Last Update
April 25 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.